Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. - Wikidata - wikimedia - TriplyDB

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

http://www.wikidata.org/entity/Q34527573

about

Assessing feasibility, compliance and toxicity of concomitant chemo-radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges.Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy.Concurrent Chemoradiation with Low-Dose Weekly Cisplatin in Locally Advanced Stage IV Head and Neck Squamous Cell Carcinoma.Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion Supportive Management of Mucositis and Metabolic Derangements in Head and Neck Cancer Patients.Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity.Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).Comparison of survival rates between patients treated with conventional radiotherapy and helical tomotherapy for head and neck cancer.Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival.Daily Cisplatin and Weekly Docetaxel versus Weekly Cisplatin Intra-Arterial Chemoradiotherapy for Late T2-3 Tongue Cancer: A Pilot and Feasibility Trial

P2860

Q33753722-DF06BAB5-BD3C-4358-97C7-DB20C905E8A8 Q35749879-B1F91689-B12B-488F-AE44-2C3C546C53E1 Q35862282-578C81D0-F12A-4CCE-90F6-761D47B3DDE2 Q36086448-391BCD08-6E61-4F5D-9239-983646DDB3FC Q36102873-2047F3EA-28C6-4BF7-A685-130D5A325294 Q36323993-1C13CE89-1E25-46E9-A0BB-380CA33BE14C Q36378279-4E8AFFDC-D333-48D5-A9E2-E3BA4C73159A Q36588745-0A935AAF-381B-4D17-A27B-B1074C5B60D3 Q36730781-E1FD3EAF-C768-4F53-88B1-B23E9B1AC5C2 Q36786765-95503B83-188C-4CF2-91A7-A435C4E598FD Q37732871-7A2541B9-C655-479E-8873-30589A1859B8 Q57824720-E6B11C42-2E20-4E46-B34D-56D1559F0B6D

P2860

Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

http://www.wikidata.org/entity/Q34527573

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@ast

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@en

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@nl

type

label

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@ast

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@en

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@nl

prefLabel

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@ast

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@en

Comprehensive IMRT plus weekly ...... rsity of Wisconsin experience.

@nl

P1433

Q34527573-556D4CB8-8F7B-4110-A0D6-E4BD643781E3

P1476

Q34527573-E8A4038D-7117-4E35-9EC8-2A78E179619E

P2093

Q34527573-3687229B-57C2-47DA-B961-402A86A687E4

Q34527573-3D5C0E4F-317C-4873-9B38-C31331964691

Q34527573-58300498-89C5-430A-8D68-8294644E654C

Q34527573-5CFF26E5-7A20-48D0-A618-9814A12660A9

Q34527573-B6AD6442-0BA4-4B0D-B865-631E612F66E5

Q34527573-CD41CF85-219B-4329-BE98-E94DB4D76836

Q34527573-F5E2ED53-5128-4903-A5A1-6838A2633E5F

P2860

Q34527573-0BBBE88C-15CA-4386-81F9-A25FB6E40C16

Q34527573-111F9534-5E08-4835-B566-1C8A46B67EE6

Q34527573-1949B7C6-3A7F-4368-AA95-2E3DBE65B834

Q34527573-2A44DBC9-6444-475C-8586-2A3E34C79885

Q34527573-2E7CF182-98D5-437A-85D5-34D7DB2040B5

Q34527573-42FC2A88-80CB-4E2A-9AD1-F43153804ED0

Q34527573-540779C5-FDEF-4071-9213-A82EBDEAEAE3

Q34527573-59B962AE-B2DF-4F21-88A5-06AFC4BA026C

Q34527573-6A4DD64C-174F-4127-B21E-9122BDA29DFD

Q34527573-73DB0294-F7F7-4B43-8AA5-FFA25D9E2901

P304

Q34527573-A2C5EE1B-B5B3-437B-A8D1-E4C9EA7B80CE

P31

Q34527573-E5332E1C-DAAF-4516-96D2-0C300C2666DE

P356

Q34527573-D1CF8446-994A-4639-92C2-84D2B323779C

P433

Q34527573-C6ADF856-EF9C-4B1B-A464-9C6ADF45FEC2

P478

Q34527573-9EF48502-9D73-4EBF-BC7D-2A5379DF71A7

P50

Q34527573-1645E4B3-3AC8-49DB-AA32-75890ED0716F

P577

Q34527573-632C0067-E489-4C42-9739-823B9C7A3958

P5875

Q34527573-D3C5A9A9-5D3C-47B1-87B7-C96450CED72B

P698

Q34527573-BC30E2D9-66A7-4636-92C2-EB076FE67A74

P932

Q34527573-22A74B19-107F-473A-BBA7-E4AFB9DE7548

P356

P1433

P1476

Comprehensive IMRT plus weekly ...... ersity of Wisconsin experience

@en

P2093

Anne M Traynor

http://www.w3.org/2001/XMLSchema#string

Deepak Khuntia

http://www.w3.org/2001/XMLSchema#string

Gregory K Hartig

http://www.w3.org/2001/XMLSchema#string

Gregory M Richards

http://www.w3.org/2001/XMLSchema#string

James F Cleary

http://www.w3.org/2001/XMLSchema#string

Paul M Harari

http://www.w3.org/2001/XMLSchema#string

Peggy A Wiederholt

http://www.w3.org/2001/XMLSchema#string

P2860

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.

The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.

Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck.

Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.

Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.

Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.

Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.

Evaluation of early and late toxicities in chemoradiation trials.

Chemoradiotherapy for locally advanced head and neck cancer.

P304

599-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HED.21224

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Søren M Bentzen

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26815214

http://www.w3.org/2001/XMLSchema#string

P698

19757422

http://www.w3.org/2001/XMLSchema#string

P932

3028434

http://www.w3.org/2001/XMLSchema#string